Latham & Watkins advised ServiceTitam Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised the underwriters. ServiceTitan, Inc., the software platform that powers the...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins advised Solaris Energy Infrastructure, Inc. and Yorktown Energy Partners X, L.P. on the offering, and Latham & Watkins advised the underwriters. Solaris Energy...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux Therapeutics, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters related to the transaction, while Latham & Watkins advised the...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Kodiak Gas Services, Inc. on the offering, and Latham & Watkins advised the underwriters. Kodiak Gas Services, Inc. (NYSE: KGS), the largest...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Viridian Therapeutics, Inc. (Nasdaq: VRDN), a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Bicara Therapeutics on the offering, and Ropes & Gray advised the underwriters. Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company, announced the...
You must be a Standard 1 Year member to access this content.
Milbank advised Viking Holdings Ltd on the offering, Latham & Watkins advised the underwriters and Ropes & Gray advised the selling shareholders. Viking Holdings Ltd (NYSE:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Dechert advised Relay Therapeutics, Inc. in the offering, and Ropes & Gray advised the underwriters. Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Kymera Therapeutics, Inc. (Nasdaq: KYMR) (Kymera), a clinical-stage biopharmaceutical company, announced its public offering of 2,830,533 shares...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop Shaw Pittman represented NNN REIT, Inc. in the offering, and Vinson and Elkins represented the underwriters. NNN REIT, Inc. (NYSE: NNN) (the “Company”), a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented UL Solutions, and Weil advised the underwriters in the offering. UL Solutions Inc., a global leader in applied safety science based in...
You must be a Standard 1 Year member to access this content.
